REXAHN PHARMACEUTICALS, INC 10-Q 9-30-2016

Company

Opus Genetics, Inc.

Filed

November 4, 2016

Period of Report

September 30, 2016

Accession Number

0001140361-16-084902

A 10-Q is a quarterly financial report filed after each of the first three quarters of a fiscal year. It includes unaudited financial statements and management commentary. Learn more about 10-Q filings →